Dr. Faisal Alagrafi is a Senior Researcher at the Healthy Aging Research Institute, King Abdulaziz City for Science and Technology (KACST), Saudi Arabia, with over 17 years of experience in biomedical research. He holds a PhD in Medical Science (Clinical Immunology) from Karolinska Institutet, Sweden, and an MSc in Cell Biology, Genetics, and Histology from King Saud University. His research focuses on cellular immunology, particularly γδ T-cell biology, immune reconstitution following allogeneic hematopoietic stem cell transplantation (HSCT), and cancer immunotherapy. His work includes investigating γδ T-cell phenotypic and clonal diversity, their association with clinical outcomes, and their therapeutic potential in hematological malignancies. His current research interests include developing innovative immunotherapeutic strategies using γδ T cells, bispecific antibodies, and combination therapies to enhance antitumor immune responses. He is also interested in translational biomedical research, biotechnology, and the development of advanced cell-based therapies
King Abdulaziz City for Science and Technology
Riyadh, Ar Riyāḑ, Saudi Arabia
Healthy Aging Research Institute
Mentor
King Saud University, Riyadh, Saudi Arabia
Healthathon, Digital Health Innovation Hackathon (2026)
Senior Scientist or Principal Investigator
King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia
01 Jan 2026 - present
Research or Laboratory Scientist
King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia
01 Aug 2008 - 31 Dec 2025
PhD student
Karolinska Institutet, Stockholm, Sweden
18 Nov 2020 - 26 Sep 2025
Project Manager
King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia
01 Jun 2018 - 01 Sep 2020